Company intelligence / Profile preview
Shanghai Jinwei Biotechnology Co., Ltd.
Shanghai（上海）, Shanghai Shi（上海市）, 中国（China）jinweibio.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Jinwei has demonstrated early clinical activity with lentiviral vector-based therapies in infectious disease (HIV) trials. Its technologies are advancing toward broader applications in cancer immunotherapy and other serious diseases. The company’s lentiviral vectors have received regulatory approval for further clinical testing in HPV indications
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Lentiviral vectorsgene therapy platformscryptic peptide technology
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Pasteur Institute (France): Exclusive licenses on lentiviral IP/patentsTheravectys S.A.S.: Licensing partner on lentivirus technologyHuashan Hospital partnership; participant in national science projects
Beyond the preview
Go deeper on Shanghai Jinwei Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Jinwei Biotechnology Co., Ltd..